Condition
HIV Primary Infection
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Unknown2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04067661Not ApplicableTerminated
A Couples-based Intervention for Transgender Women and Their Partners
NCT04799197Not ApplicableCompleted
A Multicomponent Intervention to Address Gender-based Violence in HIV
NCT05036694Not ApplicableUnknownPrimary
Diagnostic Performance of a Novel Lipoarabinomannan.
NCT04483674Phase 2UnknownPrimary
Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection
Showing all 4 trials